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Abstract
Cerebrospinal fluid (CSF) is produced by the choroid plexuses within the ventricles of the brain and circulates through the 
subarachnoid space of the skull and spinal column to provide buoyancy to and maintain fluid homeostasis of the brain and 
spinal cord. The question of how CSF drains from the subarachnoid space has long puzzled scientists and clinicians. For 
many decades, it was believed that arachnoid villi or granulations, outcroppings of arachnoid tissue that project into the dural 
venous sinuses, served as the major outflow route. However, this concept has been increasingly challenged in recent years, 
as physiological and imaging evidence from several species has accumulated showing that tracers injected into the CSF can 
instead be found within lymphatic vessels draining from the cranium and spine. With the recent high-profile rediscovery of 
meningeal lymphatic vessels located in the dura mater, another debate has emerged regarding the exact anatomical pathway(s) 
for CSF to reach the lymphatic system, with one side favoring direct efflux to the dural lymphatic vessels within the skull 
and spinal column and another side advocating for pathways along exiting cranial and spinal nerves. In this review, a sum-
mary of the historical and contemporary evidence for the different outflow pathways will be presented, allowing the reader 
to gain further perspective on the recent advances in the field. An improved understanding of this fundamental physiological 
process may lead to novel therapeutic approaches for a wide range of neurological conditions, including hydrocephalus, 
neurodegeneration and multiple sclerosis.
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Introduction
Being arguably the most sophisticated organ, the brain 
requires ample protection from mechanical and molecular 
harm. The skull provides defense against physical insults, 
while the blood–brain barrier prevents foreign and poten-
tially dangerous molecules from entering the brain. The cer-
ebrospinal fluid (CSF) contained within the ventricles and 
subarachnoid space (SAS) provides another layer of support 
by creating a chemically and mechanically stable environ-
ment that is tightly controlled by additional blood–CSF bar-
riers at the choroid plexus and arachnoid mater. Homeostasis 
in the production, circulation, and absorption of the CSF is 
therefore critical for normal brain function. Several diseases 
may arise from disturbances in the CSF system of which 
the most apparent are the ‘mechanical’ CSF disorders, e.g., 
the different forms of hydrocephalus and idiopathic intrac-
ranial hypertension. The presumed function of the CSF as 
a ‘waste-sink’ for toxic metabolites of the brain and of the 
SAS as a site of immune surveillance further suggests great 
importance of CSF homeostasis in relation to the develop-
ment of neurodegenerative and neuroinflammatory diseases 
[1].
Many fundamental questions related to the production, 
circulation, and absorption of CSF remain unanswered. 
The studies considered to be the foundation of this field of 
research were first conducted around 150 years ago and since 
then, many different investigators have debated these top-
ics and a satisfactory consensus has been difficult to reach 
[2–5]. Major reasons for this are that the CSF pathways, 
being located within the cranial cavity and spinal column, 
have been particularly difficult to access experimentally and 
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most studies have therefore been based on ex vivo prepara-
tions or injections of exogenous tracers. Both techniques 
inherently introduce artifacts that may complicate interpre-
tation of the data. It is also apparent that some of the con-
cepts that have persisted to modern times were proposed by 
researchers who were not yet aware or failed to accurately 
consider the barriers of the central nervous system (CNS).
A widely cited value for CSF volume in humans is 
140 mL and it is suggested that at least 500 mL of fluid is 
produced and cleared from the CNS every day [5]. How-
ever, it is most likely that this value for CSF volume is an 
underestimate. Recent MRI studies, while exhibiting sig-
nificant variability between subjects, have provided aver-
age craniospinal CSF volume estimates ranging from 254 
to 331 mL [6–8]. Regarding production, it is understood 
that this process is predominantly undertaken by the choroid 
plexus. However, additional roles for the blood–brain barrier 
in the parenchyma of the brain or ependymal cells lining the 
ventricles have been suggested [9, 10]. Circulation of CSF is 
complex but it is generally accepted that there is an overall 
directional flow with certain defined anatomical routes from 
the ventricles to the SAS to the sites of efflux. In addition, 
to-and-fro motions driven by arterial pulsations or respira-
tory movements are present [11–13]. On the other hand, a 
widely cited but controversial hypothesis, that of the exist-
ence of a “glymphatic” system, has proposed that a signifi-
cant portion of CSF will enter the brain along perivascular 
spaces and flush through the brain parenchyma [14]. These 
questions regarding production and circulation, despite their 
intriguing nature, are outside the scope of this review and 
the reader is instead referred to several other recent reviews 
of these topics [15–18].
One very active area of debate relates to the clearance 
pathways of cerebrospinal fluid. In most organs of the 
body, lymphatic vessels are present within interstitial tis-
sue and are responsible for draining fluid and proteins that 
have extravasated from the blood circulation [19, 20]. Even 
serous cavities, such as the peritoneal or pleural spaces, have 
lymphatic drainage through stomata that line the walls of 
these fluid spaces. The CNS on the other hand appears to 
be devoid of lymphatics not only within the brain or spi-
nal cord parenchyma but also within the pia and arachnoid 
meningeal layers that directly align the CSF-filled SAS. 
Thus, alternative mechanisms for outflow have long been 
sought. The textbook understanding is that CSF will exit the 
SAS through specialized structures, called arachnoid villi 
or granulations, that extend into the venous sinuses in the 
dura mater [3, 5]. However, as will be evident in this review, 
no anatomical mechanism for how this process occurs has 
been settled upon and, surprisingly, no solid evidence from 
in vivo physiological studies has ever been produced that 
indicate that inert tracers will drain directly from the SAS 
to the blood. On the other hand, over a hundred studies in 
several different mammalian species have shown a role for 
the lymphatic vessels in draining tracers injected into CSF. 
Despite this direct evidence, the lymphatic contribution 
toward CSF outflow has consistently been minimalized. In 
fact, for a large portion of the twentieth century, lymphatic 
outflow of CSF was barely mentioned at all in textbooks on 
the subject. It was only after renewed efforts by investiga-
tors in the 1980s and 90s that a concept of dual outflow 
pathways, both venous and lymphatic, found wider accept-
ance [21–24].
The specific pathways through which the CSF can reach 
the lymphatic system are currently an area of great contro-
versy. The bulk of the literature supports pathways through 
the cribriform plate and along cranial and spinal nerves to 
reach lymphatic vessels outside the CNS. However, in the 
last few years researchers have rediscovered a network of 
lymphatic vessels in the outermost meningeal layer, the dura 
mater, and have suggested that this could represent a more 
direct outflow route for CSF. This exciting finding has raised 
immediate questions regarding the potential mechanisms for 
this process, including how a barrier layer at the arachnoid 
mater that exists between the SAS and the dura mater could 
be traversed.
This review will first closely examine the historical and 
contemporary evidence for the three major proposed ana-
tomical pathways for clearance of CSF from the cranium: 
arachnoid projections (villi or granulations), routes through 
foramina in the skull along cranial nerves (including the 
cribriform plate) and lymphatic vessels of the dura mater. 
Next, a description of the studies on CSF outflow from the 
spine will be presented. Subsequently, a detailed account of 
the physiological in vivo studies utilizing quantification of 
tracers and/or in vivo imaging will be provided. Finally, a 
summary of the limited evidence from humans and a discus-
sion of the major open questions will attempt to set the stage 
for future work on this topic.
Arachnoid villi and granulations
The textbook model of CSF circulation states that arachnoid 
projections within the skull are the main CSF outflow site. 
Arachnoid projections are outcroppings of arachnoid tissue 
that extend through the dura into the major venous sinuses 
and the associated lacunae laterales and were first described 
in 1705 by the Italian anatomist Antonio Pacchioni [25]. 
There are considered to be two types of arachnoid pro-
jections: arachnoid villi and arachnoid granulations (aka 
Pacchionian bodies). The only major criteria to differenti-
ate between the two types of tissue is their size, with villi 
described as microscopic and granulations grossly visible 
to the naked eye [26, 27]. For this reason, granulations are 
usually only described in larger animals and not in rodents in 
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which many of the recent experiments have been performed. 
At the summit of the arachnoid projections, there is a layer 
of cells that comes into direct continuity with the venous 
sinuses of the dura [28, 29]. Thus, it would appear that these 
structures are ideally situated for drainage of CSF from the 
SAS to the venous blood (Fig. 1a).
Fig. 1  Arachnoid projections and the different models that have been 
proposed for CSF outflow to the dural venous sinus. a Lewis Weed’s 
rendering of an arachnoid villus (from [263]). The interior of the vil-
lus is composed of fluid spaces continuous with the subarachnoid 
space and contains fibers that that are connected with the arachnoid 
trabeculae. The villus projects through dural tissue to extend into the 
lumen of the superior sagittal sinus. A cap of arachnoid cells covered 
by an intact layer of endothelial cells is located at the terminus of the 
villus. b A reproduction of an image from Lewis Weed’s published 
report from 1914 [3] showing Prussian blue precipitate (gm, black 
granular material) within an arachnoid villus (av) extending toward 
the superior sagittal sinus (ss). Granules are seen in “isolated arach-
noidal clumps near the sinus lumen”. The image is acquired from a 
cat that had been injected with 2% potassium ferrocyanide and iron 
ammonium citrate into the lumbar space under a pressure of 180 mm 
 H2O for four hours. Note the large subdural space (sd) between the 
arachnoid mater (am) and dura mater (dm) which is an artifact of the 
tissue preparation. Weed also highlights the “absence of precipitate 
within the true dura tissue surrounding the arachnoidal elements” 
representing early evidence for the arachnoid barrier layer. c Vari-
ous models attempting to provide a mechanism for outflow of CSF 
and solutes through arachnoid projections (villi or granulations) have 
been proposed. Panel 1 is Weed’s original conception based upon 
Starlings forces in which favorable hydrostatic and osmotic gradients 
would exist through the endothelial cell lining to facilitate CSF out-
flow to the dural venous sinus (DVS). Hugh Davson later challenged 
this concept as no osmotic forces would develop to allow macro-
molecular solutes, such as albumin, to leave the CSF [52]. Panel 2 
is the proposal of arachnoid granulations (AG) as one-way valves, 
as conceived by Welch and Friedman [60]. When hydrostatic pres-
sure gradients are favorable, endothelial-lined channels at the end of 
the projection are open for flow of fluid and macromolecules to the 
venous sinus. When the pressure in the sinus is above that of the SAS, 
then the channels are collapsed and no flow in either direction can 
occur. These endothelial-lined channels were later identified using 
electron microscopy as infoldings of the tissue that were not continu-
ous with the SAS. Panel 3 are the various models that were proposed 
to explain how flow might occur through an intact layer of endothe-
lial cells on the cap of the projections. Panel 4 represents the concept 
of a dual layer of intact cells on the cap of the projections, one layer 
comprised of arachnoid cells and the other of venous endothelium. In 
this scenario, no outflow of CSF would normally occur through these 
structures under homeostatic conditions. However, these layers may 
be distended and eventually disrupted under conditions of high intrac-
ranial pressure, allowing for a “safety valve” mechanism for rapid 
egress of CSF. Scheme by Joachim Birch Milan
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A potential function for these structures remained elusive 
until the classic experiments of Key and Retzius published in 
1875 [2]. In human cadavers and in living dogs and rabbits, 
injections of Richardson’s blue dye were made and pathways 
to the veins were found through the projections of arachnoid 
tissue. As translated from the original German by Turner, 
“one can see that after injection into the subarachnoid space, 
the fluid fills the villi [...] then the fluid appears on their 
surface and from there it flows freely into the blood stream. 
The route is blocked only by two thin membranes. They 
are the surface of the villus and its dural sheath” [26]. Key 
and Retzius proposed that microscopic stomata were present 
between the endothelial cells of the dural sinus to allow the 
escape of the dye-filled fluid. Although criticized by later 
investigators for using high pressures for their injections 
which appeared to have led to rupture of the intervening 
membranes [30, 31], the concept by Key and Retzius of a 
drainage of CSF to veins through these specialized structures 
was highly influential.
One early point of controversy was that arachnoid 
granulations could not be found in lower vertebrates or in 
human infants [32]. Therefore, alternative mechanisms were 
sought. Harvey Cushing, working with Theodor Kocher in 
Switzerland, observed that mercury that had leaked from 
a rubber pressure bag inserted into the “subdural space” 
quickly reached the draining veins. He hypothesized that 
one-way valves must exist between the SAS and the dural 
sinuses [32]. Several other investigators around this time 
also concluded a direct transport of CSF injected dyes into 
the venous system by rapid detection within the draining 
veins of the neck or the urine [33–36]. For example, Dandy 
and Blackfan, detected a rapid absorption of phenolsulfon-
phthalein dye (phenol red) from the cerebral ventricles and 
the subarachnoid spaces and concluded that this transport to 
veins was a “diffuse process from the entire subarachnoid 
space” [37]. Meanwhile, others did not observe immediate 
outflow of dyes to the systemic circulation and were more 
inclined to believe that pathways leading to lymphatic ves-
sels were the efflux mechanism [38, 39]. The discrepancies 
between these early observations likely reflect the differ-
ences in the properties of the tracer substances (lipid solubil-
ity, toxicity etc.) that were utilized, with some possessing the 
ability to cross CNS barriers and others not. Tracer proper-
ties will be discussed in more detail below in the section “In 
vivo quantitative studies”.
With the landmark work of Lewis Weed, published in 
1914, the concept of drainage of CSF at the arachnoid villi 
that has largely persisted to the present day was established 
[3, 4, 31]. As this study has had the most influence on the 
textbook concept of the process of CSF outflow, it is worth 
examining this work in detail. In cats and dogs anesthetized 
with ether, a laminectomy was performed by a transverse 
cut of the lower thoracic or upper lumbar spinal cord and 
a cannula was inserted into the intrathecal space. Infu-
sions at slightly above normal intracranial pressure (ICP) 
(130–180 mm  H2O) of isotonic solutions of equal parts iron 
ammonium citrate and potassium ferrocyanide were then 
introduced into the spinal SAS at a slow rate. After vari-
ous times of this infusion, the animals were killed. Weed 
then perfused the animals, via intracarotid injection, with 
a solution of formalin containing 1% hydrochloric acid. In 
this manner, the formalin fixed the brain and meninges, and 
the acid precipitated to form granules of Prussian blue from 
the previously introduced salts. Through this method, he 
avoided introducing particulate matter into the SAS which 
could have obstructed potential outflow pathways. In some 
animals, instead of perfusion, he severed the head intact and 
incubated the tissue for days in a solution of formaldehyde 
and hydrochloric acid. Weed found that after short periods 
of infusion, the Prussian blue granules were mainly located 
in the basal cisterns and the cavernous sinus, and, after 
longer periods of several hours, they were found concen-
trated above the cerebral hemispheres. At this location, he 
described microscopic structures of fine, web-like interlac-
ing cords, which he termed arachnoid villi, that invaginated 
the arachnoid membrane into the dural superior sagittal sinus 
(Fig. 1b). As he was unable to locate any valve-like struc-
tures or stomata at this location through serial sections of the 
major dural sinuses, Weed argued that a process of filtration 
through an intact membrane at the cap of the arachnoid villi 
must be the transport mechanism. Weed also infused India 
ink in some animals but was unable to visualize its transport 
to peripheral tissues, instead the particulate material became 
enmeshed within arachnoid tissue in the SAS, as was also 
seen by other contemporary researchers [37, 40, 41].
Weed’s concept of outflow through arachnoid villi was 
not fully accepted by other researchers at that time. Working 
in dogs, Dandy found very few attachments of the cerebral 
hemispheres to the longitudinal, transverse, and circular 
sinuses [42]. When he physically separated the hemispheres 
from the dura and examined the animals four to six months 
later, he found no enlargement of SAS or ventricles, nor 
was any edema evident in the brain parenchyma. Weed also 
acknowledged in his original report that some earlier work-
ers had reported toxic CNS effects of ferrocyanides [34, 43], 
although in his observations the prepared solutions did not 
exhibit any obvious toxicity. However, Howarth and Cooper, 
repeating Weed’s protocols much later in dogs, found severe 
toxic effects including muscular contractions, convulsions 
and even death [44]. Another early criticism of Weed’s meth-
ods was the fact that the tissue was only analyzed ex vivo 
after formalin fixation. By the time of examination, post 
mortem diffusion of the small molecular weight substrates 
had likely occurred, as suggested by several investigators 
[45–47]. During attempts to reproduce Weed’s work, it was 
found that Prussian blue had “impregnated the cranial bones, 
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bones and ligaments of the spinal column and in cellular tis-
sue surrounding blood vessels and nerves in the neck” [45]. 
Weed acknowledged this limitation himself in a later review 
[48] and investigators working in his laboratory attempted 
to address this issue by quickly freezing the superior sagittal 
sinus and associated tissue in situ through the use of a cold 
metal plate with subsequent freeze drying of the dissected 
sample [49]. They confirmed the presence of Prussian blue 
granules in the arachnoid villi and dural sinuses, but also 
reported that the granules were within the endothelial cells 
of veins crossing through the SAS. Thus, they suggested that 
this could represent a secondary means of CSF absorption. 
However, this viewpoint did not gain wide acceptance and 
further underscores the limitation of post mortem assess-
ments of this process.
Weed and Hughson found that pressures within the 
superior sagittal sinus were usually lower than the pressure 
within the SAS [50]. However, it was also speculated that 
hydrostatic pressure gradients between the CSF and cranial 
venous sinuses are likely not always favorable to drive flow 
of CSF to the blood [48]. Therefore, Weed reasoned that 
osmotic forces according to the law of Starling must play a 
role in order to allow absorption to continue to the venous 
sinuses. In an experimental study, Weed showed that solu-
tions containing high concentrations of serum proteins, gela-
tin or casein and, thus, with higher osmotic pressure, were 
absorbed more slowly than an isotonic crystalloid solution 
[51]. He concluded that effective force driving the normal 
process of absorption of the cerebrospinal fluid is a com-
ponent of the colloid osmotic pressure of the blood and the 
hydrostatic pressure gradient derived from the difference 
in subarachnoid pressure and intracranial venous pressure 
(Fig. 1c, Model 1).
Hugh Davson noted in a review of the subject [52] that 
emerging physiological evidence that proteins could exit the 
SAS without restriction [53] argued against the presence of 
an osmotic gradient. For an osmotic gradient to be effec-
tive, membranes would have to be present that would hinder 
the outflow of proteins. However, if these membranes were 
intact, a buildup of proteins that are normally present in the 
CSF, such as albumin, would likely occur as no driving force 
would exist for their removal. This situation would be exac-
erbated during pathological situations such as meningitis 
and subarachnoid hemorrhage during which protein and cell 
content within the CSF are known to increase dramatically. 
In an experimental study in rabbits using intraventricular 
infusions of plasma or dextrans, Davson later concluded that 
the reduction of outflow observed by Weed may have instead 
been caused by an increased viscosity of the solutions or a 
possible blockage of the outflow pathways [54]. Therefore, 
in this case, the sole force driving outflow would be the dif-
ference between the hydrostatic pressures of CSF and dural 
sinus blood. This was consistent with physiological evidence 
from other investigators at the time that supported a concept 
of bulk outflow for CSF. For example, a direct relationship 
between SAS pressure and outflow has been since dem-
onstrated by several groups [55–57]. In addition, different 
molecular weight particles exhibited similar dynamics of 
outflow [58, 59], which would also be consistent with a bulk 
flow mechanism.
An anatomical basis for unrestricted bulk outflow 
was suggested by the work of Welch and colleagues who 
described open channels within arachnoid villi in isolated 
segments of dural tissue in monkeys and dogs [60, 61]. 
These investigators used excised pieces of dura containing 
villi and the superior sagittal sinus that they set up as an 
occluding membrane between two tubes. They then altered 
the pressure and flow of fluids containing different size par-
ticles through the villi. A flow from the SAS side to the 
venous sinus side occurred at a specific opening pressure as 
a hydrostatic gradient was established. An increased flow 
occurred when the perfusion pressure was increased and 
the villi became distended. When the gradient was reversed, 
flow did not occur and the villi appeared collapsed (Fig. 1c, 
Model 2). This suggested to the authors that a valve mecha-
nism must exist within the villi, similar to that originally 
proposed at the beginning of the century by Cushing [32]. 
Evaluation of the size of the particles that were able to be 
transported indicated that molecules up to the size of red 
blood cells (7.5 μm) could flow through. Examining the villi 
histologically, the authors described a circuitous network 
of tubes lined with “flattened mesothelial cells” within the 
villi that are in open communication with the lumina of the 
lacunae laterales [60]. These channels were later proposed 
to be endothelial cell lined spaces [62–64]. One must note 
that the perfusion studies were all performed post mortem 
on isolated tissues that might exhibit degradation over time. 
Therefore, it is not unlikely that pathways that are normally 
closed in the in vivo state were available for flow [26, 65]. 
Other authors suggested that apparent openings on the sur-
face of the villi or granulations had been misinterpreted and 
were actually tortuous infoldings of the arachnoid tissue, 
which present with an undulating surface on tissue sections 
[27, 66].
The story was further complicated by anatomical evi-
dence from electron microscopy that showed that the arach-
noid villi did not actually completely penetrate through the 
endothelial lining of the dural sinus which indicated that a 
barrier in the form of tight junctions between the endothe-
lial cells was present [67–69]. These researchers found that 
this non-fenestrated layer of endothelial cells was present 
even under conditions of elevated intracranial pressure 
despite an obvious distension of the villi itself. The authors 
concluded that an active process, such as micropinocyto-
sis, must be necessary to transport proteins and other high 
molecular weight substances from the CSF (Fig. 1c, Model 
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3). However, such a mechanism is again at odds with the 
physiological studies that demonstrated relatively fast and 
unrestricted bulk flow of macromolecules from the SAS to 
blood [70]. Other authors also demonstrated that transport 
could occur after death arguing against an active transport 
mechanism [71, 72].
A potential compromise between these open and closed 
models of CSF outflow was suggested by Tripathi and Tri-
pathi [73]. Extending upon work that was performed on 
the mechanism of aqueous humor outflow at the canal of 
Schlemm in the eye, it was found in primates using electron 
microscopy that a system of vacuoles within the covering 
cells of the arachnoid villus could transport solutes from the 
CSF space to the venous sinuses. It was proposed that these 
vacuoles are dynamic in nature and would occasionally form 
a continuous channel from the basal to the apical side allow-
ing bulk flow to occur (Fig. 1c, Model 3). Another potential 
mechanism was speculated to be interendothelial gaps that 
may open to flow under favorable pressure gradients [27, 
74, 75]. However, although Shabo and Brightman had also 
observed ‘narrow clefts’ between endothelial cells, when 
they perfused horseradish peroxidase (HRP) into the SAS 
they could not detect that any reaction product had crossed 
the villus endothelium [76].
Andres [77] evaluated arachnoid villi of cats and dogs and 
found that there was no difference between the composition 
of the arachnoid layer at the villus and elsewhere in the skull. 
This work was confirmed by Krisch in rats and primates 
[78], who further criticized several earlier studies demon-
strating an open communication between the venous sinus 
wall and the SAS [63, 79, 80]. She suggested based on an 
examination of the published electron microscopic images 
that cells identified as endothelial often lacked a basement 
membrane and that preservation artifacts may have led to 
a loss of intact arachnoid cells. In the anatomical prepara-
tions of Krisch, protusions into the dural sinuses appeared 
to be comprised of intact leptomeningeal layers [78]. If true, 
this would indicate that the barrier properties of arachnoid 
cell layer are present even at the regions covering the villus. 
Examination of human tissue has given further evidence to 
the concept of a continuous arachnoid cell layer at the cap of 
the arachnoid villi [29, 81, 82]. Thus, the original descrip-
tion of Key and Retzius of “two thin membranes”, in this 
case those of the arachnoid and the endothelium (Fig. 1c, 
Model 4), intervening between the SAS and venous lumen 
may ultimately be proven to be correct [2, 26].
In the end, we must reach a conclusion that anatomical 
studies have yet failed to demonstrate structures extending 
to the dural sinuses that would correlate with the observed 
physiological observations of unrestricted CSF outflow. 
What then would be the role of arachnoid villi or granula-
tions? Some authors have suggested that they may act as 
pressure valves that open to flow under increased intracranial 
pressure [18, 78, 83]. Krisch proposed a rapid “volume 
buffering” function for arachnoid projections [78]. As the 
internal framework of the granulations is continuous with 
the SAS, under conditions of elevated intracranial pressure, 
the structures will first distend and eventually pathways for 
flow through both the arachnoid and endothelium into the 
venous sinuses could develop. Experimental evidence for an 
expansion of the villus under elevated pressure conditions 
exists for many species [60, 74, 75, 84, 85]. For example, 
Gomez and colleagues investigated the effects of pressure on 
arachnoid villi morphology in monkeys [74]. As the pressure 
gradient was increased from 0 to 250  mmH2O the arachnoid 
cells and fibers within the villi were more separated, opening 
more channels for flow within the villi. The endothelial cells 
flattened and gaps developed at the cell–cell junctions which 
became larger as the pressure gradient increased. Levine 
and colleagues, also working in primates, investigated the 
vacuoles within the endothelial cells under several different 
pressure gradients and found that the number of vacuoles 
and their size was dramatically increased at higher pressures 
[79]. Although some physiological evidence for a pressure 
valve function for arachnoid projections does exist [86], fur-
ther studies in large animal models would be necessary to 
elucidate the anatomical mechanisms for outflow.
Outflow along cranial nerves
Olfactory route through the cribriform plate
The cribriform plate is the horizontal portion of the ethmoid 
bone. It derives its name from the Latin words cribrum, 
meaning sieve, and forma, meaning figure, in reference to 
the large number of foramina that allow fila olfactoria to 
extend from the olfactory bulbs to the nasal epithelium. An 
outflow of CSF through the cribriform plate into the nasal 
cavity is in fact the earliest pathway to be described. It dates 
back to the Roman physician Galen, who described that 
purification of “animal spirits” within the brain takes place 
through funnel-like structures in the plate [25]. Thomas Wil-
lis, in his work Cerebri Anatomii (1664), also suggested that 
fluid within the skull would drain out through the cribriform 
plate, however, this viewpoint was gradually lost to history 
[87, 88].
The first tracer experiment that revealed that there was 
an anatomical connection from the SAS to the nasal sub-
mucosal lymphatics was that of Schwalbe in 1869 [89]. 
Key and Retzius also demonstrated impressive filling of the 
nasal submucosal lymphatic vessels and deep cervical lymph 
nodes after injections of Richardson’s blue dye in rabbits and 
dogs, although the previously mentioned criticism regard-
ing high pressure injections in the post mortem state must 
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be again noted (Fig. 2a,b) [2]. Interestingly, Lewis Weed 
also revealed this pathway in his well-controlled studies with 
dogs, although he regarded the lymphatic route in general 
as a minor or accessory pathway of CSF outflow compared 
with arachnoid villi [3]. Mortensen and Sullivan, working 
in vivo in dogs, were able to trace a pathway through the 
plate to the nasal mucosa and then within lymphatic trunks 
along the pharynx to the deep cervical lymph nodes [90]. 
In addition to these early studies, several dozen reports in a 
wide variety of species have been published that have con-
firmed that tracers injected into the CSF will exit across the 
cribriform plate, as exemplified in Fig. 2c [36, 37, 39, 47, 
53, 56, 65, 72, 83, 91–136].
Fig. 2  CSF outflow through the cribriform plate to nasal lymphatics. 
a Reproduction of an image from Key and Retzius [2] showing the 
lower surface of a dog’s skull in which the lower maxilla and palate 
have been removed on one side to show the lymphatic vessels of the 
nasal and palatal submucosa filled with Richardson’s blue dye from 
the SAS. The dye is transported to the deep cervical lymph glands of 
the neck. b Also from Key and Retzius [2], demonstrating Richard-
son’s blue dye-filled lymphatics in the nasal submucosa of a rabbit 
injected into the “subdural” space of the brain. The authors noted that 
similar filling of vessels was observed in animals after injections into 
the SAS. c Reproduction of an image from Kida et al. [116] showing 
a decalcified coronal section from a rat that had been injected with 
India ink. Connections through the cribriform plate are evident with 
India ink particles found within lymphatic vessels on the nasal sub-
mucosa side of the plate (arrows). d Models for anatomical routes of 
CSF outflow to reach lymphatic vessels in the nasal tissue. Experi-
mental support exists for three anatomical routes for tracers to cross 
the cribriform plate alongside the olfactory nerves. Model (a) repre-
sents an outflow pathway along a contiguous subarachnoid–perineural 
space (light blue). In this model, the perineurium is a continuation of 
the arachnoid mater, however, it does not form a barrier outside of 
the skull or is only loosely adhered to the nerve. Fluid and solutes 
have unrestricted access to the interstitium of the nasal (sub)mucosa 
(brown) where they then enter the lymphatic vasculature within this 
tissue (yellow). In model (b), CSF also crosses the plate through a 
perineural space but then has a direct pathway to lymphatic capillar-
ies that surround the nerve in a collar-like fashion. Model (c) shows 
bona fide lymphatic vessels crossing the cribriform plate to directly 
access the CSF on the CNS side. In this model the arachnoid mater 
would not form a barrier in the region covering the cribriform plate. 
Scheme by Joachim Birch Milan
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Investigators have suggested at least three possible ana-
tomical pathways that may exist for CSF to penetrate through 
this structure (Fig. 2d):
1. Perineural pathways along olfactory nerve sheaths to 
reach lymphatic vessels of the submucosa through inter-
vening interstitial tissue
2. Perineural pathways along olfactory nerve sheaths to 
directly reach lymphatic vessels of the submucosa
3. Through lymphatic vessels crossing the plate that might 
directly access the SAS
The bulk of the evidence has supported the existence of 
the perineural pathway associated with the olfactory nerves 
(fila olfactoria). This pathway is described as an extension 
of the meningeal layers such that the SAS is continuous with 
the perineural space along the nerves as they exit through 
foramina within the cribriform plate [47, 123, 137]. The 
dura layer has been described to blend into the periosteum 
of the lamina cribrosa, with the arachnoid layer continuous 
with the perineurium [47, 112]. The epineural covering of 
the nerve serves as the inner boundary of this sheath. The 
perineurium gradually diminishes in size as the olfactory 
filaments become smaller as they extend into the submucosa, 
becoming one cell layer thick at the superficial submucosal 
layer [112]. Two models were originally proposed for how 
fluid could escape from these perineural spaces to reach lym-
phatic vessels of the nasal submucosa [137, 138].
The first model suggests that the perineural cells are 
loosely adhered to the olfactory axon which allows fluid 
and solutes to easily access the interstitial spaces of the 
submucosa [139]. In this model, the perineurium offers no 
barrier to solute and fluid flow from the perineural space to 
the interstitium. Additionally, no real barrier would exist 
for entry of solutes into initial lymphatic vessels within the 
interstitial tissue of the nasal submucosa, as large clefts 
between lymphatic endothelial cells have been observed 
[111], similar to other regions in the body [19, 140].
In the second model the perineurium would exhibit bar-
rier properties similar to the meninges within the skull [137]. 
This model would require cell mediated transfer of solutes 
and fluid or vacuolar mechanisms similar to those proposed 
above for arachnoid villi in order to reach the interstitial 
spaces of the nasal submucosa. This is unlikely, as the same 
objections could then be raised in reference to the many 
physiological studies demonstrating rapid bulk CSF out-
flow of macromolecules. However, one potential anatomi-
cal arrangement that could allow for an uninterrupted flow 
of CSF would be if the lymphatics directly adjoined to the 
perineural space, as proposed by Hoffman and Thiel [30] 
and by the more recent work of the group of Miles Johnston 
[83, 124]. In this version of the model, a “collar” of lym-
phatics surrounding the olfactory nerve rootlet isolates the 
perineural space from the surrounding submucosal intersti-
tial tissue. This anatomical arrangement, if truly present, 
would have no known parallel elsewhere in the body. Within 
other fluid-filled tissue spaces, such as the peritoneal cav-
ity, stomata normally are present in the mesothelial lining 
to allow direct drainage of fluid and solutes to lymphatic 
vessels [19, 141, 142].
Tracer studies have provided support for both of these 
models. Lewis Weed’s studies with Prussian blue precipi-
tate indicated that the connections were not direct, as tissue 
spaces always intervened between the perineural spaces and 
lymphatics. Several other studies performed in rabbits are 
in agreement [47, 91, 92, 108]. Bradbury and Cserr sum-
marized after injections of FITC-dextran or Evans blue: “In 
the case of the olfactory nerves, there was massive colora-
tion of the outside of the olfactory bulbs, of the surround-
ing dura, of both sides of the cribriform plate and of the 
olfactory epithelium and its submucosa. The fluorescence 
or staining of the olfactory epithelium extended forwards 
and laterally under much of the nasal mucosa and even into 
the air sinuses” [22]. Two ultrastructural studies using HRP 
and ferritin, respectively, demonstrated that these tracers 
escaped from the loose connective sheaths of the perineural 
spaces to reach the interstitial space [111, 112]. On the other 
hand, tracer studies from the group of Miles Johnston have 
supported the more direct route from the perineural spaces 
to lymphatic vessels surrounding the nerve rootlets [83]. In 
several species, Microfil was injected post mortem and dem-
onstrated filling of lymphatic vessels from the perineural 
space with very little evidence of the contrast agent in the 
connective tissue interstitium [124]. Although such a direct 
pathway is intriguing, it is important to indicate that high 
pressure injections with a viscous agent in the post mortem 
state were utilized to visualize this pathway. It may be pos-
sible that the large particles of Microfil entered and filled the 
lymphatics as a path of least resistance rather than spreading 
through the interstitial spaces of the submucosa.
A third emerging model is based on evidence from 
rodents showing that lymphatic vessels appear to cross 
through the cribriform plate which may allow them to access 
the SAS directly [116, 133, 134, 143–145]. This would offer 
an alternate pathway, one not necessarily associated with the 
olfactory nerves, for direct access of CSF and its constituents 
to the lymphatic vessels. Anatomical support for this path-
way is found from developmental studies in rats that have 
indicated that the arachnoid barrier layer of the meninges is 
not present above the cribriform plate [146] and thus would 
not accompany the olfactory nerves outside of the skull. 
Whether the arachnoid barrier layer is completely absent at 
the cribriform plate or a porous membrane remains under 
debate. According to Walter et al.: “At the place where the 
fila olfactoria enter the cribriform plate, the subarachnoid 
space formed a funnel- or pocket-like space around the fila 
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olfactoria. Although the surface of this space was covered 
with arachnoid cells, partial interruptions were occasionally 
observed in this layer” [123]. As the dura does not appear to 
be present at this location either, it is not clear whether the 
lymphatic vessels crossing to the CNS side of the cribriform 
plate can be characterized as meningeal or dural lymphatic 
vessels, as defined in the next section. Evidence for this 
direct pathway does not yet appear to exist in species besides 
rodents. Faber, working in rabbits, found that no lymphatic 
vessels could be demonstrated through the cribriform plate 
in serial sections [47]. Lowhagen et al. were also unable to 
confirm a direct lymphatic pathway in human post mortem 
specimens [117].
Some older studies utilizing injections post mortem have 
suggested pathways through the plate not associated with 
perineural spaces or lymphatic vessels [2, 94]. Later inves-
tigators have considered that the pressure used in injecting 
tracers within the cranial space may have caused artifacts 
that have ruptured existing barriers. Faber found Prussian 
blue pigmentation located within the nasal cavity, but he was 
unable to elucidate how the tracer passed through the nasal 
mucosal epithelium [47]. Several investigators, including 
Faber, have also shown that retrograde pathways also exist 
from the nasal cavity to the SAS or potentially directly to 
the brain [47, 147–149]. These pathways were implicated 
in the spread of viruses to the CNS and have recently been 
explored as a potential delivery route for pharmaceuticals 
or stem cells.
Thus, there is very strong evidence for an efflux route for 
CSF through the cribriform plate in many different species, 
although the detailed anatomical connections from the SAS 
to lymphatic vessels still need elucidation.
Optic route
Routes along other cranial nerves may also serve as addi-
tional outflow pathways. Of these, the best described are 
the optic nerves. The optic nerve is contained with a double 
sheath of meningeal tissue, with an outer fibrous layer of 
dura and arachnoid tissue and an inner layer of pia mater 
covering the nerve [150]. Magendie, who first coined the 
term cerebrospinal fluid, even provided a description that 
the CSF contained with the SAS of the optic nerve reaches 
the orbit [151]. Schwalbe demonstrated experimentally in 
1869 (translated from the original German): “The injection 
fluid flows from the subarachnoid space by the optic canal 
into the orbit and first fills the space between the inner and 
outer optic nerve sheath which thus turns out to be a continu-
ation of subarachnoid space; the mass then simultaneously 
penetrates into a space which is located between the optic 
nerve and the retractor bulbi muscle” [89]. This finding too 
has been confirmed several times in multiple species [2, 3, 
36, 37, 39, 40, 53, 56, 65, 72, 92, 95, 96, 98,99, 101–104, 
106, 109, 116, 118, 121, 122, 127, 128, 130, 135, 152–157].
The route from the distal end of the optic nerve sheath to 
the connective tissue surrounding the eye has been examined 
histologically and/or at an ultrastructural level in several spe-
cies. In rabbits, Brierley and Field found India ink parti-
cles passing through the dura-arachnoid sheath of the nerve 
at a location close to the sclera. The particles entered the 
adjacent fatty tissue. These authors were unable to confirm 
the presence of endothelial-lined lymphatic vessels within 
the orbit and showed that the spread of India ink particles 
“took place along more or less definite lines through the 
fat” [152]. De la Motte considered the arachnoid layer con-
tinuous throughout the length of the optic nerve, similar to 
the closed model that had been proposed at the olfactory 
nerve, and that phagocytosis and vesicular transport must 
be responsible for the presence of fluorescent dextran and 
horseradish peroxidase that was observed in the surrounding 
tissue [106]. Shen et al. demonstrated in the hamster that the 
continuation of the SAS within the optic nerve extends to the 
lamina cribrosa sclerae [154]. Unlike the olfactory nerves, 
both the arachnoid and dura tissue have been described to 
accompany the nerve out of the skull and together blend into 
the outer sclera layer. At this “terminal portion” of the nerve, 
ferritin particles could be seen to enter tortuous intercellular 
channels that passed through an arachnoid trabecular mesh-
work to reach the posterior intraorbital connective tissue. 
The authors concluded that the arachnoid barrier layer at the 
termination of the SAS of the optic nerve is not continuous. 
These same authors confirmed their findings in rabbits but 
in neither species could they demonstrate the pathway to 
lymphatic vessels. Kida et al. found that India ink particles 
filled the SAS to the orbit but did not enter the surrounding 
tissue, indicating that a size exclusion might be present in 
the microchannel pathways [116]. Ludemann et al. observed 
in cats that an outflow of tracers at the distal terminal por-
tion occurred [122]. They found numerous excavations in 
the SAS that breached the outer arachnoid layer to reach the 
neurothelial cells lining the dural–scleral interface. Pores 
were found in this neurothelial cell layer. Contrast agent was 
found in the conjunctival lymphatics, but no other lymphat-
ics could be demonstrated within the orbital tissue. In mice, 
lymphatics have been observed along the dural nerve sheath 
of the optic nerve and in the fascia of the optic muscles 
[143]. It is unclear at this time if either of these would rep-
resent a route for CSF from the SAS of the optic nerve to the 
conjunctival lymphatics.
There has been some debate as to the relative impor-
tance of the optic nerve route compared with the olfactory 
route. Although Bradbury and Cole could confirm outflow 
of fluorescent dyes along the optic nerve to the conjunctival 
tissue, they found that when they injected tracers directly 
into this space they could not recover the tracers within the 
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deep cervical lymph and concluded that this route was not 
nearly as important as the nasal route [153]. However, it 
has been found that the route from the orbit appears to be 
through a superficial lymphatic route rather than towards the 
deep cervical lymph nodes. From the connective tissue of 
the orbit the lymphatic vessels track alongside the angular 
and facial veins to reach collecting vessels leading to (sub)
mandibular or superficial cervical lymph nodes [98, 130]. 
In mice the route along optic nerves appears to be a signifi-
cant contributor to the CSF outflow, as tracer signals were 
found in orbit-draining collecting vessels within 10 min of 
lateral ventricle infusion and signals within the superficial 
cervical (mandibular) lymph nodes reached levels that were 
comparable to those found in deep cervical lymph nodes 
[158]. However, as some of the afferent vessels leading to 
the superficial cervical lymph nodes appear to originate from 
other sources, including the nasal cavity [130], it is impos-
sible to make any direct proportional comparison between 
outflow routes.
Other cranial nerves
The evidence for CSF outflow along other cranial nerves is 
not yet conclusive. The trigeminal nerve (CN V) has been 
implicated in several studies [40, 65, 96, 99, 101, 159, 130]. 
However, others have not seen transport of tracers past the 
trigeminal ganglion [22, 95]. As with the nasal pathway, the 
trigeminal nerve has been implicated for retrograde drug 
delivery to the CNS indicating that communication can be 
induced between the periphery and the SAS [149]. A similar 
story present itself with the facial nerve (CN VII) with some 
investigators unable to demonstrate tracer outflow further 
than the geniculate ganglion [95], yet others have described 
an outflow of CSF tracers reaching lymphatic vessels near 
the stylomastoid foramina [104, 130, 160]. Lymphatics 
have also been identified within the perineural sheaths of 
the facial nerves in mice [141].
Many investigators have demonstrated that the SAS and 
perilymph of the ear are connected through the perineural 
space of the acoustic nerve (CN VIII) [2, 3, 89, 95, 103, 104, 
161]. From the perilymph of the scala tympani, Arnold et al. 
has traced India ink particles to the lymphatic vessels of the 
middle ear mucous membrane in guinea pigs [104]. Manzo 
et al. were able to trace HRP to lymphatics in a similar man-
ner in rabbits [161]. The quantitative importance of this 
pathway to total CSF outflow remains to be elucidated, as 
other investigators have failed to demonstrate CSF-infused 
tracers reaching lymphatic vessels at this anatomical loca-
tion [22, 118].
More solid evidence exists for CSF outflow at the jugular 
foramina [45, 65, 89, 92, 104, 130]. Three cranial nerves 
exit the skull at this location: the glossopharyngeal (CN IX), 
vagus (CN X), and accessory (CN XI) nerves. Our group has 
visualized tracer leaving along the nerves exiting the jugular 
foramen with connections to lymphatic vessels leading the 
deep cervical lymph nodes [130]. This site may also be an 
important CSF egress location through meningeal (dural) 
lymphatic vessels [160], as described in the next section.
Meningeal (dural) lymphatic vessels
Reawakened interest in the pathways of CSF outflow is 
largely due to the (re)discovery of lymphatic vessels in 
the meninges of the CNS by two studies published in 2015 
[144, 162]. Both studies described a network of bona fide 
lymphatic vessels in the dura mater, the outermost of the 
three layers of meninges. These vessels were found in close 
proximity to the superior sagittal and transverse sinuses of 
the dorsal dura and, more extensively, along blood vessel 
networks of the basal skull [144]. Interestingly, the vessels 
of the dorsal region lack lymphatic valves, while sporadic 
valves were found in the vessels of the base. Since these 
studies, these vessels have also been shown to exist in both 
non-human primates and humans [145, 163, 164]. Although 
these vessels are often referred to as “meningeal lymphatic 
vessels”, or even “brain lymphatics”, these terms may lead 
to misinterpretation if these vessels are solely confined to 
the dura mater, which technically lays outside the barriers 
of the CNS.
Despite the great amount of attention in the scien-
tific community that the rediscovery of these vessels has 
received, it is important to note that several investigators 
have identified or acknowledged the presence of these 
vessels in the past [116, 159, 165–173]. Of note, Paolo 
Mascagni in 1787 is deemed to be the first to describe dura 
mater lymphatics and his images of these vessels in the base 
of the skull of humans are strikingly similar to the network 
shown in Aspelund and colleagues in mouse (Fig. 3) [144, 
165, 174]. Lymphatics within the dura mater attached to the 
skull at the jugular foramen have also been previously identi-
fied [170]. Of particular importance is the work of Andres 
in rats, who visualized dural lymphatic vessels along the 
wall of the superior sagittal sinus and in close vicinity to the 
blood vessels of the dura mater [173]. It was described that 
these lymphatic vessels left the skull at the cribriform plate, 
as well as alongside the transverse sinus or together with the 
middle meningeal artery.
One significant objection that had been repeatedly raised 
in the past to these vessels playing a significant role in 
CSF outflow is the existence of the arachnoid barrier layer 
between the SAS and interstitial tissue of the dura mater 
[159, 171, 172]. Early investigators using trypan blue dye 
demonstrated a clear compartmentalization between the dura 
and the CNS proper, with the dura staining blue only after 
intravenous injections and leptomeninges staining blue only 
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after intrathecal injections [39, 175]. The arachnoid barrier 
was examined on an ultrastructural level in many species by 
Nabeshima et al. and was described as comprised of a few 
layers of closely apposed, epithelial-like cells connected by 
extended complexes of tight junctions [176]. The arachnoid 
barrier essentially separates the CNS from the dura mater, 
which is supplied by a blood vessel network with proper-
ties similar to those in peripheral tissue. Thus, one might 
imagine that the dura mater lymphatic vessels primarily exist 
to collect extravasated fluid and solutes within this specific 
tissue, similar to most tissue beds in the body. This concept 
is supported by MRI studies in humans and primates dem-
onstrating uptake of small molecular weight contrast agents 
into the dural lymphatic vessels after intravenous injection 
[163]. Brochner et al. found that the arachnoid barrier layer 
could be identified using the junctional protein claudin-11 
and performed a series of staining in developing rats and in 
human fetal tissue [177]. They found that the barrier cell 
layer was intact around the brain, was particularly prominent 
at the base of the skull and demonstrated interruptions only 
where cranial nerves penetrated the dura-arachnoid layers. 
This is consistent with earlier work using electron micros-
copy of tissue from cats and dogs from Andres [178].
Studies utilizing CSF-injected tracers to evaluate poten-
tial pathways through the arachnoid barrier or probe the 
function of dural lymphatic vessels have provided incon-
sistent results. Krisch et al. found that the interstitial space 
of the dura mater was functionally separated from the CNS 
by intercellular clefts filled with electron dense, granular 
material [159]. These authors could not detect HRP particles 
to cross this barrier in either direction, either from the dura 
mater interstitium to the SAS after leaking from the systemic 
blood circulation or from the SAS to the dura mater after 
lateral ventricle injection. They were able to observe clear 
filling of dural lymphatic vessels only after injection of HRP 
directly into the outer meningeal layer. They thus concluded 
that these vessels drained the “hemal mileau” of the dura. 
Walter et al. similarly found that inner arachnoidal cells 
covering the dura mater in the region of the olfactory lobes 
“often took a stellate shape and formed a cellular mesh on 
Fig. 3  Dural lymphatic vessels of the basal skull in mice and humans. 
a Reproduction of a plate from Mascagni, 1787 [165]. Using injec-
tions of colored beeswax and mercury in human cadavers, dural lym-
phatic vessels (lighter colored vessels indicated by yellow arrows) 
were identified at the base of the skull alongside the middle menin-
geal arteries and veins and were found to leave the skull with these 
vessels at the foramina spinosa. b Schematic from Aspelund et  al. 
[144] demonstrating regions of the dura found to contain lymphatic 
vessels in the Prox1-GFP transgenic reporter mouse. MMA middle 
meningeal artery, PPA pterygopalatine artery, RGV retroglenoid vein, 
RRV rostral rhinal vein, SS sigmoid sinus, SSS superior sagittal sinus, 
TV transverse vein. c Close up of the region c shown in panel b, indi-
cating the proximity of the Prox1-GFP lymphatic vessels (green) to 
the branches of middle meningeal arterial (MMA) vessel network 
[perfused via intravenous DiI dye injection (red)] in an analagous sit-
uation to that described by Mascagni in humans
2440 S. T. Proulx 
1 3
the dense connective tissue of the dura mater” [123]. Despite 
numerous India ink particles located within phagocytic cells 
of this mesh, these authors could not detect particles in the 
dura mater. Butler et al. injected HRP under several different 
pressure conditions and found that tracers reached the dural 
lymphatics over the cerebral convexities in cats only under 
conditions of high pressure (> 200 mm  H2O) [172].
In contrary, Louveau et al., using a thinned skull prepara-
tion in mice was able to demonstrate uptake of Evans blue 
dye and quantum dots into dura mater lymphatic vessels near 
the superior sagittal sinus after cisterna magna injection 
[162]. This same group later found that cisternally injected 
fluorescence-labeled antibodies specific for the lymphatic 
marker LYVE-1 were able to access dural lymphatic vessels 
in subsequent whole mount preparations [179]. They pos-
tulated the existence of “hot spots” at particular locations, 
such as along the transverse sinus, at which the vessels might 
have direct access to the SAS. These potential access points 
through the arachnoid barrier have yet to be assessed on an 
anatomical level.
Our own group has been unable to confirm uptake of sev-
eral different CSF-injected tracers into the dorsal lymphatic 
network in mice [130], a result that was recently replicated 
by another study [160]. In contrast, in collaboration with the 
group of Kari Alitalo at the University of Helsinki, we found 
that pegylated dyes had some access to the basal dural lym-
phatic network, at least after injection into the brain paren-
chyma [144]. Ahn et al. also found uptake of quantum dots 
after cisterna magna injection into dural lymphatic vessels at 
the skull base with exit of tracers at the petrosquamous fis-
sure and the jugular and stylomastoid foramina [160]. Using 
immunostainings for the junctional protein E-cadherin it was 
suggested that the arachnoid barrier layer may not be intact 
at the locations in the base of the skull where the tracer 
accesses the lymphatic vessels. These authors concluded that 
uptake by basal dural lymphatics was the main route for 
macromolecular uptake and clearance of CSF. However, this 
study did not evaluate outflow routes through the cribriform 
plate or other cranial nerve locations.
Other authors have described lymphatic vessels in the 
dura mater of the optic nerves [143, 180]. Killer et  al. 
described lymphatics on optic nerve sheath of humans and 
found that tracer could penetrate the arachnoid layer when 
India ink was injected directly into the SAS of the optic 
nerve post mortem. More tracer was found within dural lym-
phatics at the bulbar end of the optic nerve. Brinker et al. 
determined that under normal conditions the arachnoid 
barrier layer is intact until the extracranial distal portion 
of the nerve where the channels previously described by 
Erlich et al. are present [181, 156]. At high injection pres-
sure, they described the arachnoid cells becoming flattened, 
an expansion of the extracellular space and the development 
of intracellular and intercellular pores. These pores were 
representative of a mechanically disrupted meningeal fluid 
barrier, as evident by passage into the orbit of X-ray medium 
or erythrocytes from autologous blood that had been injected 
into the cisterna magna.
In sum, lymphatic vessels have been localized in the 
dural meningeal layer in several different locations within 
the skull. At this time, it still remains to be determined how 
exactly and under which conditions these vessels participate 
in the drainage of CSF fluid and solutes across the arachnoid 
barrier layer.
Outflow from the spine
When compared with outflow from the cranium, the mech-
anisms for outflow of CSF from the spine have been less 
studied. Most investigators have reached agreement that out-
flow from the spine, regardless of whether it occurs through 
venous or lymphatic routes, is much less substantial than 
from the cranial region under normal conditions [3, 45, 
182–184]. Much attention has been focused at the so-called 
“subarachnoid angle” where the arachnoid membrane forms 
a cul-de-sac at the site of the emerging spinal nerve roots 
[185]. This extension of the SAS is particularly prominent 
along dorsal nerve roots. At the cul-de-sac, loose tissue con-
taining basement membrane is present between the SAS and 
the endoneurium that merges into the dorsal root ganglion. 
Researchers have long debated if and how CSF would clear 
from this space under normal physiological conditions. 
Some investigators believe arachnoid villi are present in 
this area and that these would connect to the venous plexus 
that surrounds the nerve root [186] or, alternatively, to epi-
dural tissue and lymphatics [100]. Still others believe that a 
continuous subarachnoid–perineural space extends along the 
nerves for some distance even beyond the spinal ganglion 
[187, 188]. More recent evidence has supported potential 
pathways through the arachnoid layer at this anatomical 
location to lymphatics in the spinal dura mater or epidural 
tissue [145, 189, 190].
Weed concluded in his initial studies that outflow from 
the spine must be lymphatic in nature as he was unable to 
find arachnoid villi in this region [3]. However, working in 
the same laboratory, Elman later reported the existence of 
arachnoid villi in the spine [191]. At the site of the suba-
rachnoid angle, accumulations of arachnoid tissue were 
found that permitted passage of the Prussian blue substrates 
through the dura to the tissue surrounding the nerve roots of 
the spinal cord. These arachnoid villi were not shown his-
tologically to project directly into veins until work in new-
born rats from Woollam and Millen [192]. Carbon granules 
that had been injected daily into the cisterna magna from 
birth until three weeks were found within the connective 
tissue of the villus but not in the veins itself. The authors 
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interpretation was that the colloidal carbon was carried in 
the normal outflow of CSF towards veins but was unable to 
penetrate the endothelial lining of the venous sinus, leav-
ing deposits within the core of the villi. Interestingly, car-
bon granules were also found within the lymphatic vessels 
leading towards lymph nodes on the dorsal abdominal wall. 
Welch and Pollay working in serial sections of tissue from 
two species of primates found arachnoid villi near the lum-
bar nerve roots [184]. However, only in 5 out of the 32 nerve 
roots studied were arachnoid villi directly associated with 
dural veins.
Kido et al., in human cadaver tissue, identified three types 
of arachnoid villi or granulations in the spine [193]. The 
first was localized internal to the nerve root dura mater, the 
second (and most common) reached into the dura mater and 
the third extended through the dura completely to the epi-
dural space. Dye that had been perfused into the spinal SAS 
in the cadavers was found to some cases within the lumen 
of venous sinuses, confirming earlier results from this group 
demonstrating CSF outflow of radiopaque contrast material 
during post mortem infusions in dogs [72]. In another study 
from the same group, Gomez et al. found that “at the regions 
that the pia and arachnoid fused in an irregular manner, 
prominent proliferations of arachnoid cells were frequently 
seen” [194]. Structures that gave the appearance of arach-
noid villi or granulations were found in a total of 51 nerve 
roots in three dogs and 48 nerve roots in three sheep. Prus-
sian blue that had been injected into the spinal SAS shortly 
after death were found in spaces between the arachnoid cells 
and, occasionally, the cells were separated from veins only 
by a single layer of endothelium. However, an anatomical 
pathway for CSF flow through this endothelial cell layer, and 
thus through spinal arachnoid villi, has yet to be elucidated, 
similar to the case within the cranium.
Several authors have demonstrated that a lymphatic out-
flow of tracers can occur at spinal nerve roots. Early inves-
tigators such as Quincke and Key and Retzius demonstrated 
that injected tracers were found to extend along the nerves 
for some distance from the spine [2, 40], which they took to 
indicate that a perineural pathway was open to carry CSF 
beyond the subarachnoid angle, a viewpoint more recently 
espoused by Bechter [188]. However, other groups did not 
observe India ink further than the intervertebral (dorsal root) 
ganglion when injection pressures were well-controlled [95, 
195]. Accumulations of India ink remained confined at the 
cul-de-sac of arachnoid tissue at this location which was 
referred to as “nerf de congestion” by the French authors 
and “Tuschenmattchen” by the authors writing in German. 
Brierley and Field, writing later in English, described these 
structures as “ink cuffs” [100].
In the lab of Speransky, an extensive series of experi-
ments were performed using India ink injected in dogs to 
elucidate CSF outflow pathways to the lymphatic system 
[45]. These investigators had succeeded in establishing a 
method through which the cranial and spinal subarachnoid 
spaces were separated from each other in living dogs using 
rings of muscle tissue wrapped around the spinal cord [95]. 
It was only possible to fill the lymph nodes along the abdom-
inal wall when introducing the ink into the caudal region of 
the isolated spinal space. Ink introduced in small volumes 
in the intact SAS either into the cisterna magna or at the 
caudal spine did not demonstrate significant outflow from 
the spine [168]. Two rather illuminating studies on spinal 
outflow were performed in this lab by Galkin [97, 196]. 
In one, tissue overlying the cribriform plate was separated 
from the lamina cribrosa, rupturing the fila olfactoria. The 
foramina in the cribriform plate subsequently became sealed 
by connective tissue. Under these conditions, injections into 
the caudal SAS exhibited a filling of the abdominal lymph 
nodes similar to that seen when the cerebral SAS was iso-
lated. Interestingly, the deep cervical lymph nodes remained 
unstained indicating that these are filled almost exclusively 
through the nasal route under normal circumstances [97]. 
The second study by Galkin utilized two rings of muscle 
tissue on the spinal cord to isolate three separate regions of 
the SAS: defined as upper, middle and lower regions. Injec-
tions performed into each of these regions demonstrated that 
lymphatic outflow occurred only from the cervical (through 
the nasal route) and lumbo-sacral regions, with essentially 
no outflow found from the thoracic region of the spine [196].
Brierley and Field performed injections of India ink into 
the lateral ventricle of rabbits and evaluated the outflow 
to several potential draining lymph nodes at different time 
points [100]. Examination of the table published in their 
report indicates similar results to that seen by the group of 
Speransky. At early time points India ink is found in the 
deep cervical lymph nodes, followed by the superficial cer-
vical and the sacral lymph nodes. Only at later time points 
or after multiple injections were India ink particles found 
in lymph nodes that could be draining the thoracic region. 
These authors evaluated the outflow locations at the “ink 
cuffs” and concluded that “particles pass most readily out 
of the spinal subarachnoid space from the cul-de-sac just 
proximal to the posterior root ganglion of each spinal nerve, 
especially in the region of the second and third cervical 
nerves and of the three large roots contributing to the for-
mation of the sciatic nerve” [101]. My laboratory has been 
able to repeat this finding in mice by using pegylated near-
infrared fluorescent tracer and transgenic Prox1-GFP lym-
phatic reporter mice. We were able to demonstrate that the 
outflow of tracers injected into the lateral ventricle occurs 
to lymphatic vessels predominantly at the sacral region of 
the spine [184]. The tracers then drained to the sacral and 
deep iliac lymph node chains to return to the blood via the 
thoracic duct. A primary outflow site at the caudal end of the 
spine would imply that a directional descent of CSF from its 
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site of production within the ventricles would occur under 
normal conditions. Indeed, routes for this caudally directed 
flow within the spinal column were identified both within the 
central canal, confirming earlier work [197, 198], and in the 
spinal subarachnoid space towards the lumbar sac. In fact, a 
caudal spread of radiolabeled agents has been demonstrated 
in monkeys and humans using ventriculography [199, 200]. 
Although previous investigators have found tracers within 
thoracic or lumbar nodes [116, 157], it is important to note 
that lymph in efferent lymphatic vessels from the sacral and 
iliac nodes will traverse these nodes during its passage to 
the thoracic duct [184]. Therefore, evidence of tracer within 
these nodes does not necessarily imply direct lymphatic 
drainage from these regions of the spine.
Studies from several species have found dural or epidural 
lymphatic vessels to be in abundance in the spine, particu-
larly in the cervical region [145, 168, 189, 190, 201]. How-
ever, one must assume that a functional arachnoid barrier 
is also present in these regions. Supporting this concept, 
Miura et al. was able to fill these vessels with India ink only 
under high injection pressure conditions [201]. Zenker et al. 
has examined, on an ultrastructural level, potential pathways 
through the arachnoid layer of the cervical spine in rats 
[189]. In the subarachnoid angle region (called the menin-
geal angle by these authors), the arachnoid layer is reduced 
in size to two or three layers thick and the dura mater is thus 
closely associated with the SAS. Tight junctions were not 
always found in this region. Ferritin particles which were 
infused in vivo into the cisterna magna were found to have 
penetrated the arachnoid membrane in an intercellular man-
ner and reach the dura mater. Transcellular pathways were 
also identified through uptake by arachnoid-lining cells and 
transcytosis. Macrophages, which were in abundance in the 
subarachnoid angle, also appeared to take up ferritin. The 
ferritin was found within dural lymphatics, but also within 
thin-walled veins in the dura.
Thus, a consensus has emerged that there is CSF outflow 
from the spine along spinal nerve roots, with the strongest 
evidence supporting an outflow to lymphatic vessels from 
the dorsal aspect of the lumbo-sacral region.
In vivo quantitative studies
Removal of CSF and its solutes from the ventricles and SAS 
is dependent upon bulk flow in addition to the passive dif-
fusion and/or active transport of specific constituents. This 
means that the choice of tracer will have a dramatic effect on 
the experimental results and the interpretation of such. For 
assessment of the outflow pathways of CSF, inert tracers that 
will follow the bulk flow pathways are preferred, meaning 
careful attention should be given to the molecular weight, 
lipid solubility, surface charge and the existence of known 
transporters within the CNS to blood. For example, one early 
study injected methylene blue in the CSF and detected a 
rapid outflow of this dye to the torcular venous sinuses [41]. 
They concluded that CSF must quickly exit to venous blood. 
However, we now know that methylene blue can cross the 
blood–brain barrier (after intravenous administration) due 
to its lipid solubility that allows it to easily cross plasma 
membranes [202, 203]. Another early study used phenol-
sulfonphthalein, which was found by Dandy and Blackfan 
to be present in urine minutes after an injection into the cis-
terna magna [37]. Yet, it was later found that this substance 
has active transporters that facilitate its quick efflux into the 
blood vascular system [58, 204].
The introduction of radioactive isotopes to physiologi-
cal studies in the 1940s provided a means of tracing the 
movements of naturally occurring ions or water in CSF. 
The results from these experiments appeared to show unex-
pected routes of absorption [205, 206]. Thus, in studies 
performed in humans by Sweet and co-workers [206, 207], 
radiosodium and deuterium-labeled water were administered 
intravenously, or into the ventricles or cisterna magna. By 
analyzing serial samples of CSF from a lateral ventricle, 
the cisterna magna and the lumbar sac, and from the blood, 
the authors suggested that formation and clearance of the 
fluid was occurring throughout the CNS. These conclusions 
were later criticized by Selverstone [208], a co-author of one 
of these earlier reports [206], who pointed out that these 
experiments had been misinterpreted, for an exchange of 
ions demonstrates only the permeability of a membrane and 
does not indicate that there is a flow of fluid into or out of 
the system. It was impossible to measure whether an unla-
beled ion had exchanged in the opposite direction during the 
experiments. In fact, co-infusion of unlabeled isotonic NaI 
into the CSF will dramatically reduce the efflux of I-labeled 
Na from the SAS [209]. Strikingly, in this case, the radiola-
beled sodium appears to spread within the SAS in a convec-
tive fashion similar to labeled albumin. More recent work 
using injected radiolabeled ions and water from the group 
of Bulat and Klarica, has also been interpreted to mean that 
CSF does not exhibit a directional flow through the CNS 
[210]. These authors have used these findings to support 
their claims that CSF is not produced by the choroid plexus, 
nor absorbed at specific anatomical sites (i.e., arachnoid villi 
or lymphatics). However, this work suffers from the same 
pitfalls as these earlier studies, i.e., the authors are measur-
ing tracer exchange rather than bulk flow.
Several investigators have attempted to measure the direct 
outflow of CSF to blood by injecting labeled substances in 
the ventricles and recovering these tracers in the urine or 
blood. For example, Prockop, Schanker and Brodie injected 
inulin, sucrose and mannitol into the lateral ventricle of 
rabbits and compared the dynamics in urine with injec-
tions of the same dose of substances in the blood [58]. The 
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dynamics of all three substances were similar with a delay of 
around 1 h before substances were detected in the urine after 
intraventricular injection, but all three were present almost 
immediately within the urine after intravenous injection. The 
highest molecular weight substance, inulin, was detected in 
higher quantity showing its utility as a bulk flow tracer. Data 
from Davson in rabbits appears to be a more convincing 
demonstration of direct tracer uptake to blood, as radiola-
beled albumin was evident in the blood by 30 min (the first 
time point assessed) after the initial infusion. However, it 
is important to note that after a bolus infusion of 100 μL of 
the tracer, another 100 μL bolus of artificial CSF was made 
followed by a continuous infusion of 60 μL/min of artificial 
CSF in order to “enhance the flow […] through the cerebro-
spinal fluid compartment” [70]. This constant infusion most 
likely dramatically accelerated the outflow dynamics. Mann 
et al. demonstrated that both inulin and 0.5 μm polystyrene 
beads could be detected in sinus blood of rats within three 
minutes of the start of the infusion. However, the authors 
infused the substances at 22 μL per min into the lumbar 
SAS, a rate that quickly led to intracranial pressures of over 
700 mm  H2O, far exceeding normal levels [211].
The first to attempt a quantitative study to assess the pro-
portion a macromolecular label draining by the lymphatic 
vessels was Courtice and Simmonds in 1951 [53]. These 
authors investigated the removal of Evans blue labeled blood 
plasma from the SAS of cats and rabbits. Through cannula-
tions, the dye–protein concentration was estimated at several 
time points up to 24 h in CSF, circulating blood and cervical 
and thoracic duct lymph. By comparison of the recovered 
proportions in each of these compartments, it was concluded 
that the greater part of the dye–protein appeared to have 
reached the blood by a route other than the lymphatics. 
These experiments have had a profound influence on later 
thinking (being cited in high impact journals to this very 
day [212]) and have served as evidence to minimalize the 
role that lymphatics have in the removal of macromolecules 
from the SAS. It is interesting to note that the authors report 
that in some rabbits, no dye–protein absorption to blood was 
detected until after one hour, while dye–protein was found to 
have clearly traversed the meninges through the cribriform 
plate to enter the nasal lymphatics or through the optic nerve 
to reach the retroorbital tissue.
The group of Michel Földi, repeating this type of experi-
ment in dogs [213], criticized Courtice and Simmonds on 
the grounds that it would be impossible to retrieve a sig-
nificant portion of lymph from a cannulation of one major 
lymphatic trunk leading to the deep cervical lymph nodes. 
Using a different approach, these authors directly compared 
the radioactivity in cannulated lymph to samples of femo-
ral arterial and jugular venous blood at several time points 
after introduction of radiolabeled albumin to the cisterna 
magna in dogs. They showed that the tracers were evident 
in the cervical lymphatic vessels before they were detected 
in either venous or arterial blood. It was also shown that the 
jugular venous signals were never above those in the arte-
rial blood. To the authors, this was consistent with a model 
in which lymphatic vessels were primarily responsible for 
the outflow of CSF, although later this group appeared to 
temper this viewpoint and attribute to veins the greater role 
for removal of protein and fluid [214]. Földi also developed 
a complicated surgical technique in which ligation of the 
lymph vessels or removal of lymph nodes in the cervical 
region was performed in rats and dogs [215, 216]. This led 
to quite surprising results in which a “lymphostatic encepha-
lopathy” developed that was associated with elevated ICP, 
cerebral edema and behavioral changes in the animals. 
Sadly, this pioneering work was paid little heed at the time.
In a series of well-controlled studies in rabbits, cats, and 
primates, the group of J. Gordon McComb evaluated the 
route of CSF drainage at different infusion rates of radiola-
beled serum albumin into the lateral ventricle or cisterna 
magna [56, 109, 114]. Through surgically implanted can-
nulas, the authors sampled the blood at the superior sagittal 
sinus and at the femoral artery at several timepoints after the 
initiation of the infusion. As in the earlier study by Földi, 
if tracer was exhibiting efflux through arachnoid villi then 
one would expect that the concentrations in the blood at the 
superior sagittal sinus would be higher than the concentra-
tions in the systemic blood. However, at no time point in all 
three species was this the case. Even at infusion rates four 
times higher than the initial rate, resulting in a significant 
increase in intracranial pressure, the authors could not find 
evidence of direct efflux of the tracer to blood in primates 
[114]. In addition, a delay was evident before signals were 
detected in the blood at either cannulation site. This initial 
time until detection in blood became shorter when greater 
infusion rates were used, supporting a bulk outflow mecha-
nism. Sampling several tissues at the end of the experiment, 
the authors could find little evidence for significant transport 
of tracer to the dorsal surface of the cerebral convexities 
where arachnoid villi have been found to be most abundant. 
Instead, high concentrations of radiolabeled albumin were 
found at the base of the brain, olfactory bulbs, optic nerves 
and episcleral tissue and in deep cervical lymph nodes. 
Using a similar experimental approach, the Johnston group 
examined CSF outflow of radiolabeled albumin in neonatal 
lambs. This group could detect an enrichment of tracer con-
centrations in the superior sagittal sinus blood as compared 
to vena cava, albeit only at elevated intracranial pressures 
(~ 200 mm  H2O) [120].
The group of Michael Bradbury published several studies 
in the early 1980s in which cannulations of cervical lym-
phatic vessels were made in an attempt to quantify the pro-
portion of CSF draining through this route in rabbits and cats 
[22, 108, 153]. They estimated that, in the rabbit, 30% of the 
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CSF tracer was draining within lymphatics towards the deep 
cervical lymph nodes, while in the cat the estimated amount 
was close to 13%. Their study did not take into account tracer 
that may have be transported by other lymphatic routes or 
beyond the time points that the lymph was recovered from 
the anesthetized animals. Thus, their values may be sub-
stantially underestimated. In fact, the authors were not able 
to account for up to 50% of the tracer in either species after 
subtracting for the amount present in blood or still within the 
CNS tissue at the end of the study, an observation also made 
by other groups [56, 70]. If there were direct outflow to 
blood from the SAS, one would not expect such high levels 
of tracer unaccounted for. Indeed, if phenolsulfonphthalein 
is injected into the cisterna magna, a substance identified to 
have transporters for efflux to blood, recoveries are described 
to be 100% [58]. This discrepancy suggests that other tissue 
(i.e., interstitium and/or lymphatics) intervenes in between 
the SAS and the blood. The authors attributed this outflow 
of CSF to bulk flow as different sized macromolecular trac-
ers (albumin and 150 kDa dextran) were recovered in equal 
measure [153]. An additional study by this group used an 
implanted cannula in a cervical lymphatic vessel of unanes-
thetized sheep and attributed around 32% of the outflow of 
radiolabeled albumin to lymphatics [217].
The Johnston group used a similar approach in unanes-
thetized sheep and came to a value of closer to 50% of the 
tracer recovered in lymphatic vessels cannulated in the cer-
vical region and the thoracic duct [157]. This group then 
further improved this technique using mathematical models 
based upon mass balance calculations of the dynamics of 
125I-HSA injected into the ventricles as compared to 131I-
HSA injected intravenously to account for the loss of the 
tracers over time from the plasma. The data from these mod-
els indicated that 40–48% of the CSF outflow was occurring 
through lymphatic vessels, with the remainder assumed (but 
not shown) to occur through arachnoid villi [218]. Using 
a ligation approach in rats, a similar value was obtained 
[219]. These authors also tested the effect of increasing 
ICP in anesthetized sheep [220, 221]. Cervical lymph flow 
increased substantially at increasing ICP, but never reached 
the values seen in unanesthetized animals under normal 
pressure conditions. It is important to note that an unknown 
proportion of the cervical lymph flow will originate from 
non-CNS sources (e.g., nasal tissue, middle ear) which likely 
also exhibit increased lymph formation while the animals are 
conscious. The authors proposed that the drop of CSF out-
flow resistance that has been shown to occur with increasing 
ICP [54, 222] might be a function of an enhanced lymphatic 
transport of CSF.
Several groups have shown that experimentally obstruct-
ing the outflow at the cribriform plate leads to significant 
reductions in CSF clearance to the lymphatic system in 
the neck [220, 97, 108, 223]. Bradbury and Westrop, after 
sealing the plate with cyanoacrylate glue, found that the 
recovery of 125I-albumin in deep cervical lymph on one 
side of the rabbit was reduced from 14.8% to 1.9% [108]. 
One must note that this 90% reduction in tracer recovery to 
deep cervical lymph does not mean that 90% of total CSF 
lymphatic outflow is through the cribriform plate, as alter-
nate routes were not assessed. In fact, further evidence from 
this group indicated that flow down the spine may act as 
an alternate efflux site when flow from the nasal region is 
reduced, as previously demonstrated by Galkin in dogs [97]. 
The group of Johnston inhibited transport through the nasal 
pathway by sealing the extracranial surface of the cribri-
form plate of sheep with glue or bone wax [220, 119, 223]. 
Importantly, this procedure led to significantly higher spikes 
in ICP and increased CSF outflow resistance in response 
to fluid infusions into the ventricles and, remarkably, even 
increased ICP during homeostatic conditions when a liga-
tion of the SAS of the spine was performed to block flow 
into this compartment. This indicates that, at least in sheep, 
the nasal route appears to be the most important for outflow 
from the cranial CSF space and that other potential outflow 
routes (through arachnoid villi, along other cranial nerves 
or to dural lymphatics) are not able to easily compensate.
In vivo imaging
The first in vivo imaging studies demonstrating CSF out-
flow were performed in the 1930s using X-ray [90, 98, 224]. 
Wustmann used a new contrast agent called thorotrast, which 
was a preparation of thorium dioxide suspended in a pro-
tective colloid, as a contrast agent for visualization of the 
SAS in living dogs. After injection, thorotrast found passage 
out of the cranium through perineural tissue spaces of the 
olfactory nerve towards the nasal mucosa. From this loca-
tion the contrast agent was found in the lymphatic vessels 
at the angle of the mandible and in the deep cervical lymph 
nodes. In addition, there was contrast agent evident in the 
optic nerve sheaths as far as the papilla. From here, the tho-
rium found passage into lymphatic collecting vessels in close 
proximity to facial veins to the submandibular lymph nodes. 
To a lesser extent, it was drained by the lymphatics accom-
panying the large blood vessels and cranial nerves at the 
base of the skull [98]. Mortensen and Sullivan found simi-
lar results in the same species, with thorotrast passing rap-
idly (within 30 min) to deep cervical nodes through a route 
that the authors determined was occurring along olfactory 
nerves towards the nasal mucosa and nasopharynx (Fig. 4a). 
Submaxillary lymph nodes also filled through a superficial 
network of lymphatic vessels that the authors were able to 
trace back to the bucco-nasal junction [90].
The technique was rapidly translated to the clinic [224, 
225]. One published report in Germany by Jacobi and Lohr 
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Fig. 4  In vivo imaging techniques for assessment of outflow of CSF 
tracers. a Reproduction from Mortensen and Sullivan, 1933 [90]. 
The image shows a radiograph of a dog 6  h after injection into the 
cisterna magna with thorotrast. The contrast agent is seen within 
the lymphatic vessels and the superficial and deep lymph nodes. b 
An image reprinted from Pile-Spellman et al. [110] showing a scin-
tigraphic image of a rabbit that was injected into the lateral ventri-
cle with 99mTc antimony sulfide. The sagittal image was acquired 4 h 
after injection and shows clear enrichment of radiotracer within the 
nasal region as well as in the deep cervical lymph node. c Inferior 
posterior radiograph of a cat skull 30  min after infusion of Isovist 
300 contrast medium into the cisterna magna. Besides an accumula-
tion in the nasal region (N), contrast medium (asterisk) is apparent 
in the orbital tissue and around the length of the optic nerve (O). 
Reproduced from [122] d–f Fluorescence microscopy imaging of the 
outflow of near-infrared fluorescent tracers from the CNS in Prox1-
GFP transgenic reporter mice after intraventricular injection. Panel d 
indicates accumulation of IRDye680CW dye at the cribriform plate 
(cp, white arrows) and around the optic nerves (on, white asterisks). 
tn trigeminal nerves. In e, 3 kDa dextran labeled with AlexaFluor680 
is shown exiting the orbit of the eye within Prox1-GFP+ lymphatic 
vessels. From this location the tracer drains into the mandibular (aka 
superficial cervical) lymph nodes (not shown). Panel f demonstrates 
an outflow of a 40 kDa pegylated near-infrared dye (P40D680) from 
the sacral region of the spine into Prox1-GFP+ lymphatic vessels. g 
Imaging with T1-weighted MRI of Gadospin D contrast agent show-
ing spread to and outflow from the spine after low-rate infusion 
(0.1  μl/min) into the lateral ventricle. The outflow from the caudal 
end of the spine to the sacral lymph nodes is apparent. Panels d and e 
are reproduced from [130], while f and g are taken from [184]
2446 S. T. Proulx 
1 3
described clear delineation of the lymphatics of the mandi-
ble and pharynx and cervical lymph nodes in humans after 
cisternal administration of thorotrast [226]. The authors 
described an efflux along the olfactory and optic nerve 
sheaths. Unfortunately, no images are included in their 
report. Clinical utility was short-lived, however, as it was 
soon concluded from studies in cats, dogs and monkeys 
that intracranial administration of this contrast agent was 
harmful [227]. Although evidence of removal from the CSF 
spaces along cranial nerves was found, the overall clearance 
of thorotrast was slight. The development of hydrocephalus 
was a common result with thorotrast deposition in the basal 
cisterns and accumulation in macrophages of the SAS. How-
ever, radiographic contrast agents found continued applica-
tion in animal studies. Schurr found efflux of pantopaque 
through the olfactory and optic nerve routes to submandibu-
lar and cervical lymph nodes in dogs [102]. Obliteration of 
the SAS over the cerebral hemispheres was induced by cov-
ering the brain with iodinated gauze which led to a fibrotic 
arachnoiditis. Despite the blockage of the suspected outflow 
sites at the arachnoid villi, there was no sign of hydrocepha-
lus in the dogs until the optic and olfactory routes were also 
obstructed by the pantopaque contrast agent.
Di Chiro performed cisternography with radioionated 
serum albumin or autologous CSF in human patients, most 
of whom were suffering from epilepsy but would not be 
expected to exhibit any major deficiencies in CSF circu-
lation [228, 229]. Although within one hour after lumbar 
injections, the radioactivity was clearly present in the basal 
cisterns, it took 12 h for the activity to be present over 
the convexity. At 24 h, high signal was present along the 
superior sagittal sinus. The author interpreted this finding 
as evidence for CSF streaming towards a site of outflow 
known to be rich in arachnoid granulations. However, the 
slow bulk movement of the tracer to this location would not 
agree with the expected rates of CSF turnover [230]. Other 
authors have interpreted these accumulations of radiolabeled 
proteins after cisternography to be occurring at the “dead 
ends of the CSF circulation”, rather than the major sites of 
absorption [231]. A more rapid clearance as observed in the 
basal cisterns would be evidence of faster turnover of CSF 
in these regions, which these particular authors speculated 
to be occurring through cerebral capillaries. In rabbits and 
cats, cisterna magna-injected 99Tc antimony sulfide col-
loid passed rapidly into the basal cisterns and was found 
within 5 min in the area of the olfactory bulb-cribriform 
plate (Fig. 4b) [110]. Cervical lymph node activity was first 
seen by scintigraphy after 30 min. Using a gamma counter 
to examine different tissues at the end of the experiment, 
the authors determined that a 1:2 ratio existed between the 
dose found in the deep cervical lymph nodes versus the liver. 
From this analysis, the authors estimated that 1/3 of the 
dose had exited along nerve routes to the lymphatic system, 
however, this calculation does not take into account outflow 
to other lymph node groups nor adjust for continued lym-
phatic transport of the radiocolloid through the lymph nodes 
to the blood.
Advancements in radiographic techniques and contrast 
agents have been utilized to further demonstrate lymphatic 
outflow in animals. Brinker et al., using dynamic X-ray 
microscopy in rats, found contrast media in the basal cis-
terns and nasal cavities soon after the start of infusion into 
the cisterna magna (Fig. 4c) [118]. Some minutes later, the 
contrast media highlighted the SAS of the optic nerve, the 
perilymphatic space of the inner ear, and the SAS above 
the cortical hemispheres and near the transverse sinuses. 
In another study using serial computed tomography scans, 
diatrizoic acid ester nanoparticles (240 nm diameter) were 
localized at the deep cervical lymph node of rabbits within 
1 h of intraventricular injection. The authors estimated that 
17% of the dose was present in the deep cervical lymph 
nodes at the peak enhancement time of 12 h after injection 
[232]. Similarly, Murtha et al. utilized contrast-enhanced CT 
scans to assess the CSF efflux routes in spontaneously hyper-
tensive rats. The authors performed 3D scans every 5 min 
until 60 min after infusion of Ultravist contrast agent into the 
lateral ventricles and detected signals in the nasal tissue and 
deep cervical lymph nodes. The authors also detected spread 
of the contrast agent into the spinal SAS, but at no point 
could they detect signal at the superior sagittal sinus [127].
Fluorescence imaging techniques in rodents have recently 
been employed to visualize tracer outflow to lymphatic ves-
sels. Mathieu et al. utilized a whole animal hyperspectral 
fluorescence imaging system to detect quantum dot efflux to 
the superficial cervical lymph nodes of mice [233]. Recently, 
researchers have been taking advantage of transgenic lym-
phatic vessel fluorescent reporter mice [234, 232]. One 
example of these mice, the Prox1-GFP mouse, was used by 
our group to map the outflow pathways of a CSF-injected 
pegylated near-infrared dye, a 40  kDa macromolecular 
tracer, to lymphatic vessels (Fig. 4d–e). We found tracer 
outflow along several cranial nerves, including olfactory, 
optic and facial nerves, with filling of lymphatic vessels 
immediately outside the skull [130]. Using non-invasive 
dynamic imaging, we demonstrated that tracers reached 
the collecting lymphatic vessels leading to the mandibu-
lar (or superficial cervical) lymph nodes before they were 
detectable within the systemic blood. The delay in signal 
enhancement that was apparent in the peripheral blood cir-
culation (as measured at the saphenous vein) was consistent 
with the cannulation studies in larger animals performed 
by earlier investigators [56, 109, 114, 213]. Low molecular 
weight compounds exhibited similar transport dynamics to 
peripheral blood but with lower overall efflux, likely due 
to diffusion of these intraventicularly injected compounds 
across the ependyma into the brain and retention at various 
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locations in the CNS. The dynamic near-infrared fluores-
cence assay to quantitively measure the CSF injected tracers 
in the systemic blood allows a sensitive noninvasive readout 
of CSF turnover through all potential efflux sites. We have 
used this approach to demonstrate a slower clearance of CSF 
in aged mice [130], a more rapid CSF turnover in awake as 
compared to anesthetized conditions [184] and a reduced 
efflux in glioblastoma-bearing mice [135].
Magnetic resonance imaging techniques hold great prom-
ise to evaluate the pathways of CSF flow in a dynamic, three-
dimensional fashion with simultaneous anatomical visuali-
zation. Several investigators have explored the outflow of 
CSF using MRI techniques in animal studies. In an early 
study, Di Chiro et al. injected Gadolinium-DTPA into the 
cisterna magna of normal dogs and were able to visualize 
the efflux of the contrast agent across the cribriform plate 
into the nasal submucosa [236], replicating an earlier study 
in the same species using cisternograms [105]. The authors 
characterized this finding as CSF rhinorrhea, a condition 
in which CSF fluid leaks into the nasal cavities, however, 
they likely were visualizing the normal CSF efflux in this 
species. Muldoon et al. used Combidex, a dextran coated 
ultrasmall superparamagnetic iron oxide (USPIO) contrast 
agent injected into the lateral ventricles of rats [237]. They 
detected by MRI an accumulation, confirmed by histological 
methods, in both superficial and deep cervical lymph nodes 
by 2 h after injection. The authors, however, were unable to 
map the routes from the SAS to the lymph nodes. Another 
early MRI study injected the low molecular weight contrast 
agent, gadoteridol, into the cisterna magna of guinea pigs 
[121] and performed MRI scans every 30 min under differ-
ent ICP conditions. The authors visualized and quantified a 
clear enhancement of the nasal (sub)mucosa and periorbital 
regions that was observed at earlier time points and seen 
at increased intensity when ICP was elevated. Almost no 
enhancement was observed in proximity to the superior sag-
ittal sinus throughout the 4 h experiment.
More recent studies have utilized T1-weighted MRI and 
gadolinium-labeled contrast agents to map CSF flow path-
ways and efflux routes in rodents. Although not focused on 
determining the CSF efflux sites, a study by Gakuba et al. 
in isoflurane-anesthetized mice clearly shows enhancement 
of Gd-DOTA in what appears to be a continuous pathway 
through the cribriform plate, to the nasal (sub)mucosa and 
nasopharyngeal region to the deep cervical lymph nodes 
within 5 min of cisterna magna injection [238]. A study 
from our laboratory using gadolinium-labeled macromol-
ecules injected into the cisterna magna has also demon-
strated this rapid efflux route through the cribriform plate, 
as well as enhancement of contrast agent around the optic 
nerves and jugular foramina [135]. In a recent publication, 
however, Ahn et al. have concluded from MRI in rats that 
efflux routes at the base of the brain, presumably through 
meningeal lymphatic vessels, are the major drainage route to 
the deep cervical lymph nodes [160]. As mentioned before, 
this study did not evaluate the perineural routes through the 
nasal and optical regions. In fact, the positioning of the MRI 
coil did not appear to allow an assessment of these efflux 
routes. Therefore, the relative proportion of cranial CSF 
efflux through routes at the base of the skull versus perineu-
ral routes still needs to be determined.
It is to be expected that tracer injections, particularly 
when performed in a bolus fashion at high volumes and/
or within short time periods, could alter the physiological 
flow patterns of CSF. This appears to be particularly appar-
ent when injections are made into the intrathecal space of 
the spine [129, 131, 239] where a volume-dependent cranial 
spread of imaging tracers over time can be visualized. We 
have attempted to limit these effects by infusing MRI con-
trast agents in the lateral ventricle of mice using an indwell-
ing cannula at rates (0.1 μL/min) far lower than estimated 
rates of CSF production in mice (~ 0.35 μL/min) [5]. Using 
this protocol, near-infrared imaging results were validated 
that demonstrate a caudal-directed flow and efflux of CSF 
at the sacral end of the spine to the draining sacral and deep 
iliac lymph nodes (Fig. 4f-g) [184]. Although MRI contrast 
agent showed accumulation at nerve roots along the length 
of the spine, there was no obvious efflux to lymphatics at any 
other level of the spinal cord. Further studies are needed to 
assess the anatomical differences at the nerve roots of the 
sacral region compared with other regions of the spine.
Evidence from humans
Unlike in animals, evidence of defined CSF outflow path-
ways in humans is lacking. Early studies involving tracer 
injections in cadavers have provided evidence for routes 
through arachnoid granulations [2] and to the nasal sub-
mucosal lymphatics [2, 93, 94]. More recently, Lowhagen 
et al. filled India ink into the olfactory groove of cadavers 
without neurological disease and traced it through the cri-
briform plate along perineural routes [117], while Johnston 
et al. injected Microfil into the SAS of cadavers and could 
demonstrate filling of lymphatic vessels within the nasal 
submucosa [124].
Other insights on CSF outflow in humans have come from 
neuropathological assessments. Since arachnoid villi have 
long been considered the major efflux site, the morphol-
ogy of these structures has been examined post mortem in 
cadavers of patients that have died from clinical conditions, 
such as intracranial hemorrhage or meningitis. In one of 
the first studies of this nature, post mortem evaluation of 
arachnoid granulations demonstrated infiltration of inflam-
matory cells in meningitis and red blood cells after hemor-
rhage [240]. The authors speculated that these pathological 
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manifestations would impair the drainage function of these 
structures. Several authors have since confirmed that eryth-
rocytes will accumulate in arachnoid projections after suba-
rachnoid hemorrhage [241–243]. On the other hand, Low-
hagen found red blood cells and iron-laden macrophages in 
abundance in the perineural spaces of the olfactory nerves 
and in the nasal submucosa after subarachnoid hemorrhage 
[117]. Another study identified red blood cells in deep cer-
vical lymph nodes in a patient who died a few days after 
subarachnoid hemorrhage [244]. Red blood cells were also 
found to fill the SAS of the optic nerve. Although intact 
erythrocytes were not found within the orbital tissue out-
side of the nerve sheath, blood breakdown products, such as 
hemosiderin could be located at this location with a Berlin 
blue staining [244]. Caversaccio et al. found a significantly 
higher incidence of deep cervical lymph nodes containing 
iron in patients who had died from intracerebral hemorrhage 
versus cadavers without intracranial lesions [245].
In a provocative new study from a Spanish group, the 
authors utilized nasal swabs in an attempt to identify bio-
markers in patients that had suffered from stroke. The 
authors were able to differentiate patients that had suffered 
from hemorrhagic stroke compared with ischemic stroke 
by the amount of iron in the nasal exudate. Although this 
study was preliminary, consisting of samples from only 20 
patients, it serves as in vivo clinical evidence that CSF waste 
products may be cleared through nasal pathways, at least 
during pathological conditions [246].
Since the rediscovery of dural lymphatic vessels there 
has been a renewed push to image potential CSF outflow 
pathways in humans. These studies thus far have not been 
conclusive. Absinta et al. found that dural lymphatics could 
be visualized with MRI alongside the SSS in humans and 
primates [163]. These authors found that a low molecular 
weight contrast agent injected intravenously showed uptake 
into the lymphatics, while macromolecular contrast agents 
stayed confined to the blood vessels of the dura. Thus, while 
this study demonstrated that these vessels were functional, 
they were shown draining the dura mater interstitial fluid, 
rather than CSF. Another MRI study was able to visualize 
these vessels without contrast agent and found using a time-
of-flight angiography technique that the lymphatic vessels 
demonstrated flow opposite to the flow of blood within the 
SSS. Thus, these vessels appeared to be draining towards the 
olfactory region [247].
De Leon et al. performed intravenous injection of two 
different low molecular weight radiotracers known to cross 
the CNS barriers and were able to highlight a potential efflux 
of CSF through the cribriform plate. Dynamic imaging with 
PET was superimposed on MRI images from each patient 
and showed clear enhancement of the superior nasal tur-
binates [248]. Eide et al. performed MRI imaging of deep 
cervical lymph nodes at several time points after intrathecal 
injection of gadobutrol in patients suffering from several 
types of CSF disorders. Lymph nodes showed a minor signal 
enhancement which peaked at 24 h [249]. A more recent 
study from this group has shown what appears to be an 
enrichment of signal at the parasagittal dura at 24 to 48 h 
after the intrathecal injection, which they interpret may be 
indicative of CSF flow towards lymphatic vessels in the dor-
sal dura [250]. These dynamics of signal enhancement near 
the superior sagittal sinus thus would be similar to those 
seen by Di Chiro using cisternography [228, 229]. It should 
be noted that low molecular weight gadobutrol also exhibits 
significant diffusion into the brain tissue and is thus not ideal 
for visualizing bulk flow CSF pathways [251]. Finally, a 
recent SPECT study by Verma et al. has provided evidence 
in healthy subjects for a delay in clearance dynamics after 
intrathecal administration of a 99mTc-DTPA tracer [252]. The 
authors were able to visualize the spread of the tracer from 
the lumbar region of administration, to the basal aspect of 
the cranium and subsequently to the bladder for elimination. 
As the clearance from the blood of such a low molecular 
weight tracer would be very rapid, this delayed enhancement 
in the bladder indicates that there are no major efflux path-
ways from the SAS to blood vessels. Although the number 
of enrolled subjects was quite low, the exciting data points 
towards a prominent role for lymphatic outflow pathways for 
CSF egress in humans.
Conclusions and open questions
The existing evidence from animal and human studies for the 
various CSF outflow pathways is summarized in Fig. 5. This 
current review of the literature has highlighted the signifi-
cant issues with the existing dogma that CSF efflux occurs 
through arachnoid projections to the venous system. Despite 
the lack of solid evidence for these structures draining CSF, 
the textbook concept has persisted almost in the same form 
as described by Lewis Weed in 1914. Even so, no consensus 
has been reached regarding a mechanism for outflow through 
arachnoid projections. There has been little anatomical study 
of these structures in recent decades with the exception of 
a few isolated studies, none of which directly support the 
notion that arachnoid projections are potential sites of sig-
nificant fluid flow [253, 254, 250].
There has been intense focus on dural lymphatic vessels 
since their rediscovery in 2015 [144, 145, 160, 162, 179, 
255–260]. Recent studies have found significant changes in 
CSF clearance, altered pathology in mouse models, or even 
cognitive defects, after ablation of the dural lymphatic ves-
sels along the superior sagittal or transverse sinuses and it 
has been hypothesized that these effects are due to the dor-
sal lymphatic vessels playing a key role in CSF clearance 
and CNS immunosurveillance [179, 255, 259]. Although 
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intriguing, it would appear that this theory is inconsistent 
with earlier experimental evidence and is further challenged 
by the findings in several studies that do not support the 
existence of a functional connection between CSF spaces 
and the interstitial space of the dura mater [3, 78, 130, 172]. 
This pathway, along with potential clearance mechanisms for 
brain interstitial fluid, are matters of controversy that need 
further exploration [16, 17, 261].
As is clear from this review, there is overwhelming 
historical evidence for perineural outflow pathways for 
CSF that have barely been acknowledged in several recent 
publications [160, 255, 258, 260, 262]. Of the three major 
proposed mechanisms for CSF outflow, the extracranial por-
tions of cranial nerves and the region of the spinal nerves 
near the dorsal root ganglions are the only routes where bar-
riers at either the arachnoid or endothelial cell layers have 
consistently been found to be lacking, allowing for bulk 
outflow as shown in physiological studies. Thus, the experi-
mental and anatomical evidence in multiple species from 
rodents to primates point to perineural pathways being the 
most important pathway for CSF outflow. Ultimately, the 
question in humans will not be definitely answered until a 
Fig. 5  An overview of the evidence for routes of CSF outflow. A 
qualitative assessment of the level of supporting evidence for various 
CSF outflow pathways was made based on the number of published 
studies, uniformity of the results across different species and plausi-
bility of the anatomical and physiological mechanisms. Experimental 
support appears to be strongest for an outflow of CSF at the cribri-
form plate with lymphatic vessels carrying the fluid and solutes to 
the deep cervical lymph nodes. Outflow also appears to be evident at 
the optic nerves and at the base of the skull through several possible 
foramina either in a perineural manner or through dural lymphatics. 
Evidence also exists for outflow from the spine to lymphatic vessels, 
particularly in the lumbar or sacral regions. CSF outflow has been 
detected in a limited number of studies in mice to the dural lymphatic 
vessels on the superior aspect of the skull. There is little support for 
an outflow to arachnoid villi or granulations under normal condi-
tions, however, this route may become recruited during conditions of 
increased intracranial pressure. Scheme by Joachim Birch Milan
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method of sensitively and specifically imaging the egress 
of CSF can be established in the clinic. The alignment of 
evidence across mammalian species should, however, be suf-
ficient to make clinicians and researchers critically question 
the textbook view of CSF outflow and to seek an improved 
understanding of the clearance pathways to the lymphatic 
system and the potential implications of these connections 
to the periphery for multiple neurological disorders.
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